All Journals > Infection Control and Hospital Epidemiology > November 2007 > SSTBJ Infections in Hospitalized Patients

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

November 2007

Volume 28, Number 11
Infect Control Hosp Epidemiol 2007;28:1290–1298
0899-823X/2007/2811-012$15.00
DOI: 10.1086/520743
Original Article

Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes

Benjamin A. Lipsky, MD;

John A. Weigelt, MD;

Vikas Gupta, PharmD, BCPS;

Aaron Killian, PharmD, BCPS;

Michael M. Peng, PhD, MPH

From the Veterans Affairs Puget Sound Health Care System and the University of Washington, Seattle, Washington (B.A.L.); the Medical College of Wisconsin, Milwaukee, Wisconsin (J.A.W.); Cardinal Health Clinical Research Group, Marlborough, Massachusetts (V.G., A.K., M.M.P.).

Background.Infections involving skin, soft tissue, bone, or joint (SSTBJ) are common and often require hospitalization. There are currently few published studies on the epidemiology and clinical and economic outcomes of these infections, whether acquired in the community or healthcare setting, in a large population.

Objective.To characterize outcomes of culture‐proven SSTBJ infection in hospitalized patients, using information from a large database.

Design.We identified patients hospitalized in 134 institutions during 2002‐2003 for whom specific International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes and a culture‐positive SSTBJ specimen were recorded. Patients were classified into 4 clinical groups based on the type and clinical severity of infection. Patients in each group were further classified on the basis of whether their infection was community acquired or healthcare associated and whether it was complicated or uncomplicated.

Results.We identified 12,506 patients with culture‐positive infections and categorized them as having cellulitis (37.3%), osteomyelitis or septic arthritis (22.4%), surgical wound infection (26.1%), device‐associated or prosthesis infection (7.2%), or other SSTBJ infection (6.9%). Monomicrobial infection was reported for 59% of patients, 54.6% of whom had Staphylococcus aureus as the etiologic agent. Of all S. aureus isolates recovered, 1,121 (28.0%) of 4,007 were resistant to methicillin. Healthcare‐associated infections accounted for 27.2% of cases and were associated with a significantly greater mortality rate, a longer length of stay, and greater hospital charges, compared with community‐acquired infections. Patients with a complicated infection (78.4%) had a significantly greater mortality rate, a longer length of stay, and greater hospital charges, compared with patients with an uncomplicated infection.

Conclusions.SSTBJ infections are frequent among hospitalized patients. S. aureus caused infection in more than 50% of the patients studied, and 28.0% of the S. aureus isolates recovered were resistant to methicillin. Healthcare‐associated and complicated infections are associated with a significantly higher mortality rate and more prolonged and expensive hospitalizations. These findings could assist in projects to revise current management strategies in order to optimize outcomes while restraining costs.

Received February 20, 2007; accepted June 5, 2007; electronically published October 3, 2007.

Address reprint requests to Benjamin A. Lipsky, MD, VA Puget Sound Health Care System (S‐111‐GIMC), 1660 South Columbian Way, Seattle, Washington 98108‐1597 ( or ).

Cited by

Brad Spellberg, George H. Talbot, Helen W. Boucher, John S. Bradley, David Gilbert, W. Michael Scheld, John Edwards, Jr., and John G. Bartlett, for the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (2009) Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials. Clinical Infectious Diseases 49:3, 383-391
Online publication date: 1-Aug-2009.
Paul B Cornia, Heather L Davidson, Benjamin A Lipsky. (2008) The evaluation and treatment of complicated skin and skin structure infections. Expert Opinion on Pharmacotherapy 9:5, 717-730
Online publication date: 1-May-2008.
CrossRef
Close Popup